I've made no secret about my liking for the MedTech company Carl Zeiss Meditec (CZMWF). This is, to my mind one of the best companies in MedTech not only due to the company's portfolio, patents, and ...

Please provide your email address to receive an email when new articles are posted on . Carl Zeiss Meditec AG will acquire Dutch Ophthalmic Research Center in 2024. The transaction is valued at ...

Carl Zeiss Meditec (CZMWF) is a company that I've reviewed a few times, going from an overall "HOLD" rating to a "BUY" rating when the company dropped down to an undervalued price. I actually bought a ...

Even after decades of experience developing eye-related devices under its belt, Carl Zeiss Meditec is still looking to expand its ophthalmic portfolio. The German company—a subsidiary of the larger ...

ZEISS, a global optics and optoelectronics firm, identifies India as a rapidly growing market driven by a young population and evolving consumer trends. With investments expanding into a new ...

German optics giant Carl Zeiss AG has signaled a major commitment to India by opening its first global capability center (GCC) in Bengaluru and announcing plans to double its local workforce to 5,000 ...

Find your next quality investment with Simply Wall St's easy and powerful screener, trusted by over 7 million individual investors worldwide. If you are wondering whether Carl Zeiss Meditec is simply ...

Global optics and optoelectronics major ZEISS is betting big on India, one of its top three fastest-growing markets for vision products, with the country's expanding youth population driving demand ...

Narrow-moat Carl Zeiss Meditec AFX reported second-quarter earnings that were in line with our expectations. Total sales were up 13.3% year over year driven by double-digit growth in ophthalmology, or ...

Carl Zeiss Meditec delivered a 5% revenue decline and a 550-basis-point decrease in adjusted EBITA for its fiscal first quarter. Full-year guidance was pulled in January but is expected be reinstated ...